Moberg Pharma AB (OSTO:MOB) EV-to-Revenue : 773.26 (As of May. 28, 2024)

View and export this data going back to 2011. Start your Free Trial

What is Moberg Pharma AB EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Moberg Pharma AB's enterprise value is kr634.07 Mil. Moberg Pharma AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was kr0.82 Mil. Therefore, Moberg Pharma AB's EV-to-Revenue for today is 773.26.

The historical rank and industry rank for Moberg Pharma AB's EV-to-Revenue or its related term are showing as below:

OSTO:MOB' s EV-to-Revenue Range Over the Past 10 Years
Min: -21.72 Med: 2.75 Max: 2126.33
Current: 773.26

During the past 13 years, the highest EV-to-Revenue of Moberg Pharma AB was 2126.33. The lowest was -21.72. And the median was 2.75.

OSTO:MOB's EV-to-Revenue is ranked worse than
99.22% of 1022 companies
in the Drug Manufacturers industry
Industry Median: 2.3 vs OSTO:MOB: 773.26

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-28), Moberg Pharma AB's stock price is kr23.90. Moberg Pharma AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was kr0.02. Therefore, Moberg Pharma AB's PS Ratio for today is 1,405.88.

Moberg Pharma AB EV-to-Revenue Historical Data

The historical data trend for Moberg Pharma AB's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moberg Pharma AB EV-to-Revenue Chart

Moberg Pharma AB Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

273.43

527.73

Moberg Pharma AB Quarterly Data
	Mar19	Jun19	Sep19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															906.35	192.94	-	-	728.93

Competitive Comparison of Moberg Pharma AB's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Moberg Pharma AB's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Moberg Pharma AB's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Moberg Pharma AB's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Moberg Pharma AB's EV-to-Revenue falls into.

Moberg Pharma AB EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Moberg Pharma AB's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	634.073	/	0.82
	=	773.26

Moberg Pharma AB's current Enterprise Value is kr634.07 Mil.
Moberg Pharma AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.82 Mil.

Moberg Pharma AB (OSTO:MOB) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Moberg Pharma AB's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	23.90	/	0.017
	=	1,405.88

Moberg Pharma AB's share price for today is kr23.90.
Moberg Pharma AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.02.

Moberg Pharma AB EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Moberg Pharma AB's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Moberg Pharma AB (OSTO:MOB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Moberg Pharma AB (OSTO:MOB) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

MB8:Germany

Address

Gustavslundsvagen 42, 5th Floor, Bromma, Stockholm, SWE, SE-167 51

Website

https://www.mobergpharma.se

Moberg Pharma AB is a Swedish pharmaceutical company focused on commercializing proprietary innovations based on drug delivery of proven compounds. The company develops and markets consumer healthcare products that relieve pain and treat skin conditions, mainly nail fungus. The Company's main product, MOB-015, is a novel topical treatment for onychomycosis It has a single operating segment, the development, and commercialization of medical products. Moberg Pharma has commercial agreements with partners in Europe and Canada, among others.